• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4615863)   Today's Articles (133)   Subscriber (49393)
For: Hirabayashi K, Okada E. Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer. Cancer 1993;71:2769-75. [PMID: 7682148 DOI: 10.1002/1097-0142(19930501)71:9<2769::aid-cncr2820710914>3.0.co;2-m] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Number Cited by Other Article(s)
1
Soltani A, Tazikeh-Lemeski E, Javan MB. A comparative theoretical study on the interaction of pure and carbon atom substituted boron nitride fullerenes with ifosfamide drug. J Mol Liq 2020. [DOI: 10.1016/j.molliq.2019.111894] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
2
Osmanoğlu YE, Tokatlı A, Sütçü K, Osmanoğlu Ş, Ucun F. Conformational, IR, NMR, and EPR analysis of ifosfamide by density functional theory calculation. MONATSHEFTE FUR CHEMIE 2016. [DOI: 10.1007/s00706-016-1824-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
3
Pang H, Feng T, Lu H, Meng Q, Chen X, Shen Q, Dong X, Cai L. Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy. Cancer Invest 2016;34:167-72. [PMID: 27057601 DOI: 10.3109/07357907.2016.1144061] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
4
Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, Lou G, Li K. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. J Surg Oncol 2011;105:206-11. [DOI: 10.1002/jso.22052] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2011] [Accepted: 07/08/2011] [Indexed: 11/07/2022]
5
Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, Zhang Z, Li Q, Xu W, Li Z, Wang D. Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma. Jpn J Clin Oncol 2010;40:425-31. [DOI: 10.1093/jjco/hyp183] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
6
The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy. Gynecol Oncol 2009;113:200-4. [DOI: 10.1016/j.ygyno.2009.02.008] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2008] [Revised: 02/03/2009] [Accepted: 02/07/2009] [Indexed: 11/17/2022]
7
Nagai N, Mukai K, Hirata E, Jin HH, Komatsu M, Yunokawa M. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma. Med Oncol 2007;25:214-21. [PMID: 17968681 DOI: 10.1007/s12032-007-9023-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2007] [Accepted: 10/03/2007] [Indexed: 10/22/2022]
8
Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2007;104:36-40. [PMID: 16889822 DOI: 10.1016/j.ygyno.2006.06.034] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2006] [Revised: 06/21/2006] [Accepted: 06/27/2006] [Indexed: 11/23/2022]
9
Yoshiyama Y, Yamaguchi K, Matsuo K, Kurokawa M, Kanke M. The effect of fosfomycin on nedaplatin-induced nephrotoxicity in rats. J Infect Chemother 2005;11:14-7. [PMID: 15729482 DOI: 10.1007/s10156-004-0361-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2004] [Accepted: 11/11/2004] [Indexed: 10/25/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA